Abstract
Neonatal lupus erythematosus (NLE) is an inflammatory syndrome in the fetus or neonate associated with the presence of anti-Ro(SSA) and anti-La(SSB) antibodies in the mother. It is characterized by a combination of dermatologic, hematologic, hepatic, and cardiac manifestations. NLE has been reported in twins; we describe neonatal lupus erythematosus occurring in triplets.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adrenal Cortex Hormones / therapeutic use
-
Antibodies / analysis
-
Autoantigens / immunology
-
DNA / immunology
-
Erythropoietin / therapeutic use
-
Humans
-
Immunoglobulins, Intravenous
-
Infant, Newborn
-
Lupus Erythematosus, Systemic / complications
-
Lupus Erythematosus, Systemic / genetics
-
Lupus Erythematosus, Systemic / physiopathology
-
Lupus Erythematosus, Systemic / therapy*
-
Platelet Count
-
Platelet Transfusion
-
RNA, Small Cytoplasmic*
-
Ribonucleoproteins / immunology
-
Skin Diseases / etiology
-
Triplets*
Substances
-
Adrenal Cortex Hormones
-
Antibodies
-
Autoantigens
-
Immunoglobulins, Intravenous
-
RNA, Small Cytoplasmic
-
RO60 protein, human
-
Ribonucleoproteins
-
SS-A antigen
-
Erythropoietin
-
DNA